🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Rachel Halford

The Hepatitis C Trust

ORCID: 0000-0003-4569-2824

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field”.

Hepatitis B virus resistance to nucleos(t)ide analogue therapy: WHO consultation on questions, challenges, and a roadmap for the field

The Lancet Microbe(2025)10.1016/j.lanmic.2025.101076

N/A

0.373DataRank · unranked

11 citations

Jolynne Mokaya, Tongai Maponga, Anna Kramvis, Geoffrey Dusheiko, William L. Irving +39 more

Strategic treatment optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

Wellcome Open Research(2021)10.12688/wellcomeopenres.16594.1

N/A

0.292DataRank · unranked

6 citations

Sarah Pett, Leanne McCabe, Christopher R. Jones, Richard Gilson, Sumita Verma +20 more

Highly replicating hepatitis C virus variants emerge in immunosuppressed patients causing severe disease

Nature Communications(2025)10.1038/s41467-025-67174-w

N/A

0.208DataRank · unranked

3 citations

Tomke Arand, Ha Gyu-Thomas Seong, Christian Heuss, Margaret Tulessin, Zhiqing Wang +49 more

Strategic Treatment Optimization for HCV (STOPHCV1): a randomised controlled trial of ultrashort duration therapy for chronic hepatitis C

medRxiv(2021)10.1101/2021.01.22.21250208

N/A

0DataRank · unranked

0 citations

Sarah Pett, Leanne McCabe, Christopher R. Jones, Richard Gilson, Sumita Verma +20 more